

The Food and Drug Administration (FDA) is feeling a bit of pressure to release clearance to an experimental drug to

One of the biggest recent breakthroughs in cardiovascular medicine has been the development of a new class of cholesterol lowering

Regeneron Pharmaceuticals, Inc., appears to be riding the wave of aging baby boomers to amazing success with sales of the